OREX PHARMA PVT. LTD
GST : 27AAACO0984E1ZJ

LevoSulbutamol Sulphate IHS

Get a Price/Quote

LevoSulbutamol Sulphate IHS Specification

Extraction Type
Synthetic

Molecular Weight
379.47 g/mol

Heavy Metal (%)
0.002%

Solubility
Freely soluble in water, practically insoluble in ethanol (96%), in methylene chloride

Storage
Store in a cool, dry, well-ventilated area, away from incompatible substances

Molecular Formula
C13H21NO3H2SO4

Odour
Odourless

Loss on Drying
1.0%

Melting Point
Approximately 131-133C

Particle Size
Passes through 80 mesh

Ph Level
4.0 - 5.0 (1% solution)

Shelf Life
2 years

Smell
Odourless

Color
White

Poisonous
NO

Structural Formula
(C13H21NO3)2H2SO4

Taste
Slightly bitter

EINECS No
251-506-2

HS Code
29349900

Medicine Name
LevoSulbutamol Sulphate IHS

Chemical Name
LevoSalbutamol Sulphate

CAS No
34391-04-3

Type
Active Pharmaceutical Ingredient (API)

Grade
IHS

Usage
Used in treatment of bronchospasm in reversible obstructive airway disease

Purity(%)
98.0%

Appearance
White or almost white powder

Physical Form
Solid

Bulk Density
0.30 to 0.70 g/cm3

Assay (by dried basis)
98.0% - 101.0%

Residual Solvents
Complies as per IHS standard

Endotoxins
Not detected

Sulfate Ash
0.2%

Identification
By IR and HPLC, complies with IHS standard

Specific Optical Rotation
+1.10 to +1.20 (C=1 in 0.1N HCl)

pH (1% w/v solution)
4.0 to 5.0

Chloride
0.1%

Related Substances
Total impurities 1.0% (by HPLC)

About LevoSulbutamol Sulphate IHS

Pharmaceutical API | Orex Pharma Pvt Ltd

Product Overview

Orex Pharma Pvt Ltd offers Levosalbutamol Sulphate IP for pharmaceutical companies seeking quality-focused active pharmaceutical ingredients (APIs) for respiratory medicine formulations. Levosalbutamol Sulphate is a bronchodilator ingredient used in the development and manufacture of pharmaceutical products designed to help relieve bronchospasm and improve airflow in patients with respiratory conditions.

With a focus on quality, product consistency, and customer-oriented service, Orex Pharma Pvt Ltd serves the sourcing needs of pharmaceutical manufacturers, formulation companies, bulk drug buyers, pharmaceutical distributors, and international trading partners. We aim to support domestic and global procurement requirements through professional communication, product documentation, and dependable business relationships.

Product Specifications

Product Name: Levosalbutamol Sulphate
Pharmacopoeial Standard: IP, subject to the applicable product specification
Product Category: Active Pharmaceutical Ingredient (API)
Therapeutic Category: Respiratory Medicine / Bronchodilator
Primary Application: Manufacturing of respiratory pharmaceutical formulations
Industry: Pharmaceutical and Healthcare
Supply Market: Domestic and international markets, subject to regulatory and commercial requirements
Company: Orex Pharma Pvt Ltd

Pharmaceutical Applications

Levosalbutamol Sulphate is used as an active ingredient in the development and manufacture of suitable respiratory pharmaceutical formulations. Depending on the approved formulation, applicable specifications, and regulatory requirements, its applications may include:

Inhalation and respiratory solutions
Oral liquid formulations
Other approved pharmaceutical dosage forms
Respiratory medicine product development and manufacturing

Why Choose Orex Pharma Pvt Ltd?

Orex Pharma Pvt Ltd understands the importance of product quality, reliable sourcing, and consistent supply in the global pharmaceutical industry. We aim to build long-term business relationships with pharmaceutical companies and international buyers through a professional, customer-focused approach.

Our product offering is intended to support pharmaceutical procurement teams seeking:

Quality-focused pharmaceutical API sourcing
Product specifications and technical documentation
Certificate of Analysis (COA), where available
Bulk procurement enquiries
International pharmaceutical sourcing partnerships
Professional support for product and commercial enquiries

Global Supply and Business Enquiries

Orex Pharma Pvt Ltd welcomes enquiries from pharmaceutical manufacturers, API distributors, pharmaceutical importers, formulation developers, and bulk drug purchasers worldwide.

For information regarding Levosalbutamol Sulphate IP, including product specifications, quality documentation, packaging options, minimum order quantity, pricing, and export availability, contact Orex Pharma Pvt Ltd directly.

Orex Pharma Pvt Ltd Your Business Partner for Pharmaceutical API Sourcing and Global Pharmaceutical Supply.

Comprehensive Quality Assurance

LevoSulbutamol Sulphate IHS is designed in adherence to rigorous safety and quality protocols, with full compliance to IHS standards through IR and HPLC identification. Its purity and assay values (98.0%-101.0%) guarantee consistent therapeutic activity. Each batch undergoes precise testing for impurities, chloride, sulfate ash, and heavy metals, ensuring product integrity and safety throughout its shelf life.

Reliable and Effective Bronchodilator

This API is a preferred choice in pharmaceutical production for its proven efficacy in managing bronchospasm associated with reversible obstructive airway diseases. The product's exceptional solubility in water and stable physical characteristics facilitate smooth formulation, enhancing both efficiency and patient outcomes.

Optimal Handling and Storage

LevoSulbutamol Sulphate IHS is best stored in a cool, dry, well-ventilated place, away from incompatible materials. It remains stable when proper storage is observed, maintaining optimal quality for up to two years. The white powder passes through 80 mesh, supporting diverse manufacturing requirements.

FAQ's of LevoSulbutamol Sulphate IHS:

Q: How is LevoSulbutamol Sulphate IHS identified and tested for quality?

A: LevoSulbutamol Sulphate IHS is identified using Infrared (IR) and High Performance Liquid Chromatography (HPLC) methods, with all parameters verified to comply with IHS standards. Each batch is also analyzed for assay (98.0-101.0%), impurities, residual solvents, and various chemical limits.

Q: What is the primary use of LevoSulbutamol Sulphate IHS in pharmaceutical formulations?

A: This API is primarily used in medicines for the treatment of bronchospasm in reversible obstructive airway disease, including asthma. Its bronchodilator properties help relax airway muscles and ensure better airflow.

Q: When should LevoSulbutamol Sulphate IHS be stored and handled with special care?

A: It should always be handled in a controlled environment. Store the powder in a cool, dry, and well-ventilated area, away from incompatible substances, to maintain its potency and prolong shelf life up to two years.

Q: Where is LevoSulbutamol Sulphate IHS typically used or exported?

A: It is widely used by pharmaceutical manufacturers globally for producing inhalers, tablets, and solutions. The product can be supplied by exporters, manufacturers, and suppliers meeting international quality standards.

Q: What benefits does the high purity of LevoSulbutamol Sulphate IHS offer to end users?

A: Its high purity (98.0%) minimizes the risk of adverse reactions and ensures predictable efficacy, supporting the development of high quality and effective respiratory therapies for patients.

Q: How does LevoSulbutamol Sulphate IHS enhance the manufacturing process?

A: Thanks to its optimal bulk density, particle size uniformity, and water solubility, this API integrates efficiently into pharmaceutical production lines, ensuring smooth blending and consistent dosages.

Tell us about your requirement